Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03024112 · ClinicalTrials.gov registry record · NA
Impact of Prophylactic High Flow Nasal Oxygen in Post-Operative Thoracic Surgical Patients
A NA study of Post Operative Pulmonary Complications, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
- 1
- Study location
NCT03024112 is a NA study of Post Operative Pulmonary Complications that has completed, run by University of Colorado, Denver. The registered enrollment target is 51 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03024112, a NA study of Post Operative Pulmonary Complications, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
- 1
- Study location
Study Summary
The Investigators goal was to study the effect of high flow nasal cannula oxygen (HFNC) on the rate of post-operative pulmonary complications in thoracic surgical patients. The Investigators hypothesis is that prophylactic HFNC oxygen, as compared to standard oxygen treatment, will reduce the incidence of postoperative pulmonary complications, improve post-operative pulmonary function, and reduce Intensive Care Unit (ICU) and hospital length of stay.
Conditions Studied
Interventions
- DEVICE Heated humified high-flow nasal cannula Oxygen
- OTHER Standard oxygen therapy
Study Locations (1)
Colorado
- Unversity of Colorado Hospital - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2013-08 |
| Est. Completion | 2015-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03024112
The ClinicalTrials.gov registry entry for NCT03024112 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Post Operative Pulmonary Complications appearing as the primary indexed condition, and to 2 interventions - of which Heated humified high-flow nasal cannula Oxygen is the first listed.
NCT03024112 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT03024112 about?
NCT03024112 is a clinical study titled "Impact of Prophylactic High Flow Nasal Oxygen in Post-Operative Thoracic Surgical Patients". The Investigators goal was to study the effect of high flow nasal cannula oxygen (HFNC) on the rate of post-operative pulmonary complications in thoracic surgical patients. The Investigators hypothesis is that prophylactic HFNC oxygen, as compared to standard oxygen treatment, will reduce the incide...
What is the current status of trial NCT03024112?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2013-08. Estimated completion is 2015-06.
What conditions does trial NCT03024112 study?
This clinical trial studies the following conditions: Post Operative Pulmonary Complications.
What interventions are being tested in trial NCT03024112?
The interventions under investigation include: Heated humified high-flow nasal cannula Oxygen (DEVICE), Standard oxygen therapy (OTHER).
Who is sponsoring clinical trial NCT03024112?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03024112 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Operative Pulmonary Complications
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.